IP Library Granted Patent US 8,053,604
Granted Patent B2
US 8,053,604 · App. 12/694,658 · Granted Nov 8, 2011

Process for preparation of diphosphine compounds and intermediates for the process

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,053,604
App. No.
12/694,658
Granted
Nov 8, 2011
Kind
B2
Abstract

A production method of a compound represented by the formula wherein R 1a , R 1b , R 1c , R 1d , R 1e , R 1f , R 2a , R 2b , R 2c , R 2d , R 2e and R 2f are the same or different and each is a hydrogen atom and the like, and R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 and R 10 are the same or different and each is a hydrogen atom and the like, or a salt thereof, which comprises reacting a compound represented by the formula wherein X is a leaving group and other symbols are as defined above, or a salt thereof, with a phosphine-borane complex represented by the formula wherein the symbols are as defined above, or a salt thereof, in a solvent in the presence of an amine and a nickel catalyst, is provided.

Claims (5)

1. A production method of a phosphine-borane complex represented by the formula

wherein R 3′ , R 5′ , R 6′ and R 8′ are each a hydrogen atom, a lower alkyl group or a lower alkoxy group, R 4′ and R 7′ are each a fluorine atom, a chlorine atom, a tert-butyl group, a mono-lower alkylamino group or a di-lower alkylamino group, and R 9′ and R 10′ are each a hydrogen atom or a lower alkyl group (R 3′ and R 4′ , and R 7′ and R 8′ may form a lower alkylenedioxy group) (provided that R 3′ , R 4′ , R 5′ , R 6′ , R 7′ , R 8′ , R 9′ and R 10′ are not hydrogen atoms at the same time), or a salt thereof, which comprises reducing a compound represented by the formula

wherein each symbol is as defined above, or a salt thereof, with lithium aluminum hydride in the presence of cerium chloride and sodium borohydride.

2. A phosphine-borane complex represented by the formula

wherein R 3′ , R 5′ , R 6′ and R 8′ are each a hydrogen atom, a lower alkyl group or a lower alkoxy group, and R 4′ and R 7′ are each a fluorine atom, a chlorine atom, a tert-butyl group, a mono-lower alkylamino group or a di-lower alkylamino group (R 3′ and R 4′ , and R 7′ and R 8′ may each form a lower alkylenedioxy group) (provided that a compound wherein R 5′ and R 6′ are hydrogen atoms, and R 3′ and R 4′ , and R 7′ and R 8′ form a methyldioxy group is excluded), or a salt thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 9, 2018
From: TAKEDA PHARMACEUTICAL COMPANY LIMITED
To: SPERA PHARMA, INC.
Reel/Frame 046293/0489 →